Solvay SA

ENXTBR:SOLB Lagerbericht

Marktkapitalisierung: €2.8b

Solvay Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Die Gewinne von Solvay sind mit einer durchschnittlichen Jahresrate von -27.5% zurückgegangen, während die Gewinne der Branche Chemicals um 0.5% pro Jahr zurückgingen. Die Umsätze sind zurückgegangen mit einer durchschnittlichen Jahresrate von 23%.

Wichtige Informationen

-27.52%

Wachstumsrate der Gewinne

-27.55%

EPS-Wachstumsrate

Chemicals Wachstum der Industrie23.20%
Wachstumsrate der Einnahmen-23.03%
Eigenkapitalrendite-1.61%
Netto-Marge-0.54%
Nächste Ertragsaktualisierung29 Jul 2026

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Analyse-Update Apr 19

SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook

Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.
Analyse-Update Apr 02

SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value

Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.
Analyse-Update Mar 19

SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value

Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.
Analyse-Update Mar 04

SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades

Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.
Analyse-Update Feb 18

SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades

Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.
Analyse-Update Feb 03

SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings

Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.
Analyse-Update Jan 19

SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price

Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.
Analyse-Update Jan 05

SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price

Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.
Analyse-Update Dec 14

SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks

Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.
Analyse-Update Nov 29

SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures

Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.
Analyse-Update Nov 15

SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline

Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.
Analyse-Update Oct 31

SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals

Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.
Analyse-Update Oct 17

La Rochelle Expansion And Energy Transition Will Secure Future Success

Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.
Analyse-Update Oct 03

La Rochelle Expansion And Energy Transition Will Secure Future Success

Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.
Analyse-Update Sep 04

La Rochelle Expansion And Energy Transition Will Secure Future Success

Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.
Analyseartikel Jan 24

Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)

It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...
Analyseartikel Jan 06

Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679

The board of Solvay SA ( EBR:SOLB ) has announced that it will pay a dividend on the 22nd of January, with investors...
User avatar
Neue Analyse Dec 25

Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth

Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.
Analyseartikel Dec 21

Solvay's (EBR:SOLB) Dividend Will Be €0.679

Solvay SA's ( EBR:SOLB ) investors are due to receive a payment of €0.679 per share on 22nd of January. The dividend...
Analyseartikel Oct 17

Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Solvay SA ( EBR:SOLB ) shareholders would be excited to see that the share price has had a great month, posting a 25...
Analyseartikel Sep 18

Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?

Key Insights Solvay's estimated fair value is €57.91 based on 2 Stage Free Cash Flow to Equity Solvay is estimated to...
Analyseartikel Aug 28

Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk

It's not a stretch to say that Solvay SA's ( EBR:SOLB ) price-to-sales (or "P/S") ratio of 0.6x right now seems quite...
Analyseartikel Aug 08

Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point

Solvay SA's ( EBR:SOLB ) earnings announcement last week was disappointing for investors, despite the decent profit...
Analyseartikel Jul 14

Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyseartikel Jun 14

Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Solvay fair value estimate is €50.62 Current share price of...
Analyseartikel May 29

Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?

While Solvay SA ( EBR:SOLB ) might not have the largest market cap around , it led the ENXTBR gainers with a relatively...
Analyseartikel Apr 24

Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Solvay SA ( EBR:SOLB ) shareholders have had their patience rewarded with a 26% share price jump in the last month...
Analyseartikel Mar 10

Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market

Solvay SA's ( EBR:SOLB ) price-to-earnings (or "P/E") ratio of 2.3x might make it look like a strong buy right now...
Analyseartikel Nov 20

Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?

Key Insights Solvay's estimated fair value is €144 based on 2 Stage Free Cash Flow to Equity Current share price of...
Analyseartikel Nov 06

Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13

Solvay SA ( EBR:SOLB ) will increase its dividend from last year's comparable payment on the 17th of January to €1.13...
Analyseartikel Nov 02

The Return Trends At Solvay (EBR:SOLB) Look Promising

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Analyseartikel Oct 19

Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analyseartikel Aug 16

Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?

Today we're going to take a look at the well-established Solvay SA ( EBR:SOLB ). The company's stock received a lot of...
Analyseartikel Aug 02

Returns At Solvay (EBR:SOLB) Are On The Way Up

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...

Aufschlüsselung der Einnahmen und Ausgaben

Wie Solvay Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.


Gewinn- und Umsatzhistorie

ENXTBR:SOLB Einnahmen, Ausgaben und Erträge (EUR Millions)
DatumEinnahmenGewinnAllgemeine und VerwaltungskostenF&E-Ausgaben
31 Mar 264,645-2553527
31 Dec 254,7463050923
30 Sep 254,90615446423
30 Jun 254,95413945622
31 Mar 255,07519742222
31 Dec 245,13022341934
30 Sep 245,218-6444541
30 Jun 245,3381845843
31 Mar 245,57112748445
31 Dec 236,025-3752647
30 Sep 23497-384-83-187
30 Jun 233,542-34146-98
31 Mar 236,038495377-23
31 Dec 227,97988956546
30 Sep 2215,4421,8591,384350
30 Jun 2213,8951,6591,342324
31 Mar 2212,5231,1761,274310
31 Dec 2111,4349431,233325
30 Sep 2110,5756481,208316
30 Jun 219,9826081,188314
31 Mar 219,631-1,1681,172316
31 Dec 209,714-1,1251,212300
30 Sep 2010,006-1,2161,224309
30 Jun 2010,514-1,8721,256315
31 Mar 2011,055-1341,320322
31 Dec 1911,227-1181,331323
30 Sep 1911,3471111,355316
30 Jun 1911,4097641,378315
31 Mar 1911,3497671,392306
31 Dec 1811,2996761,379297
30 Sep 1811,1877751,399298
30 Jun 1810,9877481,397288
31 Mar 1810,9537301,413288
31 Dec 1710,9848201,437290
30 Sep 1710,8517711,416283
30 Jun 1710,6947651,409285
31 Mar 1710,0577171,359279
31 Dec 1610,0445391,363284
30 Sep 169,1683171,320277
30 Jun 169,5122481,315276
31 Mar 1610,1462201,337281
31 Dec 1510,0833551,296271
30 Sep 1511,0683251,321270
30 Jun 1510,9293111,297265

Qualität der Erträge: SOLB ist derzeit unrentabel.

Wachsende Gewinnspanne: SOLB ist derzeit unrentabel.


Analyse von freiem Cashflow und Gewinn


Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: SOLB ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 27.5% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von SOLB verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: SOLB ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Chemicals (-1.3%) erschwert.


Eigenkapitalrendite

Hohe Eigenkapitalrendite: SOLB hat eine negative Eigenkapitalrendite (-1.61%), da es derzeit unrentabel ist.


Kapitalrendite


Rendite auf das eingesetzte Kapital


Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/12 02:26
Aktienkurs zum Tagesende2026/05/12 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Solvay SA wird von 34 Analysten beobachtet. 10 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Robert BateBarclays
Katie RichardsBarclays
James StewartBarclays